Advertisement
Advertisement
Trending on Urology Times
1
UGN-501 enters phase 1 testing for recurrent non–muscle invasive bladder cancer
2
Alicia Morgans, MD, discusses cognitive outcomes with darolutamide vs enzalutamide
3
Infertility care: Examining geographic gaps in access
4
Treating MIBC as a systemic disease reshapes bladder preservation
5